%) • Statoil O4 operating results better than ests, dps maintained, fcf breakeven lowered (trading +7.5%) • Astrazeneca profit meets estimates as Brilinta sales rise, revenue guidance downgraded (trading -4.4%) • Daimler O4 revenues beat ests, ebit touch light, dividend inline, stock has been weak (tr